• Illumina entered a strategic collaboration with Integrated DNA Technologies to connect IDT oncology library prep with DRAGEN secondary analysis.
• Partnership targets end-to-end somatic oncology research workflows for custom hybrid-capture panels, aiming to cut analysis time and improve consistency.
• Includes a DRAGEN Somatic app optimized for degraded FFPE samples, including a new low-quality FFPE analysis mode.
• Initial workflow is available now for FFPE; a cfDNA liquid-biopsy targeted version is planned for next year.
• Output is designed to be compatible with Illumina Connected Insights for variant interpretation and reporting.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Illumina Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202606010858BIZWIRE_USPR_____20260601_BW355944) on June 01, 2026, and is solely responsible for the information contained therein.